Skip to main content

Table 1 Baseline characteristics of the study participants by treatment arm at the Dafra health district medical centre, Burkina Faso, 2008–2010

From: In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

Intention to treat population mean ± standard deviationASAQ N = 220AL N = 220Total N = 440
Gender m/f, %45.4/54.655.6/44.650.5/49.6
Age, year6.4 ± 3.26.4 ± 3.16.5 ± 3.1
Height, cm114.3 ± 19.4114 ± 19.5114.15 ± 19.4
Weight, kg19.1 ± 7.518.9 ± 8.019.01 ± 7.7
GMPD, parasitaemia/µl445674707445803
  1. AL artemether–lumefantrine, ASAQ artesunate plus amodiaquine, GMPD geometric mean of parasite density